Tag: Precipio

It’s Inevitable

It’s Inevitable

It’s closing in on a year, March 25th to be exact, of Precipio’s stock price not meeting Nasdaq’s listing price requirement. And it’s now down to the wire for management to make good on their claim in avoiding a reverse split to remain listed on the exchange. So, what now? Apparently, the rumor is that…

Read More Read More

Precipio – Undervalued?

Precipio – Undervalued?

According to Merriam-Webster, the definition of undervalue is a verb meaning: to value, rate, or estimate below the real worth. So does this apply to Precipio? At this current point in November, I would say it does. Precipio, Inc. is a growing company in the burgeoning liquid biopsy space that is visibly executing a strategy…

Read More Read More

Precipio, Inc. – PRPO

Precipio, Inc. – PRPO

I’ve been watching the ebb and flow of the market, keeping an eye out for potential accelerated growth candidates and have identified a possible gem. This pick is Precipio, Inc. (PRPO). This small cap company is in the business of providing cancer diagnostic products and services to the oncology market. Precipio is expanding the potential…

Read More Read More